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6ABSTR ACT
There is an increasing need for inter-hospital transports of seriously ill children as a result of 
centralization of intensive care for children to dedicated pediatric intensive care units (PICU). 
This thesis has explored the short-and long-term outcomes of critically ill children after trans-
port by a specialized pediatric transport team to a PICU. In order to investigate the effects of 
high altitude on transported children, a novel method was introduced to improve the perfor-
mance of a device for regional oxygen saturation (rSO2) monitoring working in a transport 
environment.  
In Study I, outcomes of critically ill children acutely transported to PICU by a specialized 
pediatric transport team were retrospectively compared to a control group of children acutely 
admitted to the same PICU but through other routes. Transported children were younger, 
sicker and stayed longer in PICU and their use of PICU specific therapies was higher. The 
transport per se did not increase the risk of death irrespective of transport distance. 
Age and risk score related differences in short-and long-term survival among transport-
ed patients were evaluated in Study II. Median follow-up time for survivors was 4.4 years. 
Survival in neonatal patients was high after discharge from intensive care, and patients with 
a Predicted Death Rate (PDR) > 50% showed no mortality after the 30-day follow up. In con-
trast, there was clinically significant late mortality for the whole cohort, especially in those 
transported multiple times. 
In Study III we analyzed the impact of an arterial blood gas sample (i.e. the PaO2/FiO2 
ratio) on the Pediatric Index of Mortality2 (PIM2) score and its derived probability of death 
(%). The PIM2 and probability of death only became more accurate if PaO2/FiO2 was available 
for the respiratory admission group, and when a rather high severity of illness was expected.
The aim of Study IV was to investigate the applicability of near-infrared spectroscopy 
(NIRS) data during transport. The ability to distinguish between real and artefact-related 
events increased considerably by removal of zero values and “floor-effect values” and then 
using a filtering technique on the NIRS signal to reduce noise in the signal without loss of the 
original signal structure. 
In Study V, rSO2 with NIRS registration from cerebral (rSO2-C) and splanchnic (rSO2-A) 
areas during air ambulance transports of critically ill children was investigated in relation to 
the effect of altitude ≥ 5000 feet. Both rSO2-C and rSO2-A decreased significantly at altitude 
≥ 5000 feet compared to baseline in a majority of patients. In most patients rSO2-A decreased 
more than rSO2-C ≥ 5000 feet as expressed by the rSO2-C/rSO2-A ratio, which was > 1 in 67% 
of patients at baseline and > 1 in 77% of patients at altitude ≥ 5000 feet.
In conclusion, this thesis has addressed various aspects of children in need of transport 
to pediatric intensive care. Acute pediatric inter-hospital transports can be performed with-
out increasing the mortality risk regardless of transport distance if performed by a specialized 
team. There is a notable late mortality after the 30-day follow up for the transported group 
as a whole. An arterial blood gas sample for the PIM2 score is only needed when the patient 
has respiratory reason for admission and a rather high severity of illness is expected. Reliable 
NIRS data can be obtained during transport when cleared for artefacts and smoothed by a 
noise-reduction algorithm. Both rSO2-C and rSO2-A decreased as an effect of altitude ≥ 5000 
feet, however rSO2-C was better preserved than rSO2-A
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LIST OF ABBR EVIATIONS 
ABG   Arterial blood gas
AAP  American academy of   
 pediatrics
AAP SOTM American academy of   
 pediatrics section on   
 transport medicine
AUC  Area under the curve
ANZCTR Australian New Zealand   
 Clinical Trials Registry
ANZPIC Australian New Zealand   
 pediatric intensive care
CO2  Carbon dioxide
CPAP  Continuous positive  
 airway pressure
CPR  Cardiopulmonary  
 resuscitation 
CRRT   Continuous renal  
 replacement therapy
ECMO  Extra corporeal  
 membrane oxygenation
ETCO2  End-tidal carbon dioxide
FiO2  Fraction of inspired oxygen
GAMUT Ground and air medical   
 quality transport database
HbO2  Oxygenated hemoglobin
HbR  Deoxygenated  
 hemoglobin
ICU  Intensive care unit
IQR  Inter quartile range 
LOS  Length of stay
MPE  Mean prediction error
NICU  Neonatal intensive care unit
NIRS  Near-infrared spectroscopy
NO  Nitric oxide
PaO2  Partial pressure of arterial  
 oxygen
PaO2/FiO2 Ratio of partial pressure   
 arterial oxygen and fraction  
 of inspired oxygen 
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PDR  Predicted death rate
PETS  Pediatric emergency   
 transport service
PIM  Pediatric index of mortality
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PRISM  Pediatric risk of mortality 
 score
RSME  Root mean square prediction  
 error
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rSO2  Regional oxygen  
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 Assessment of Social Services
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1  INTRODUCTION
The origin of this thesis is a specialized pediatric transport service, PETS 
(Pediatric Emergency Transport Service), which emanates from The De-
partment of Pediatric Perioperative Medicine and Intensive Care at Astrid 
Lindgren Children’s Hospital, Karolinska University Hospital in Stockholm, 
Sweden.
PETS, which operates around the clock all year round, covers the entire 
country of Sweden and performs international retrievals as well when neces-
sary. The transport service started as a project in 2005, after realization that 
there were many seriously ill children treated in general intensive care units 
(ICU) in hospitals around Sweden, who would perhaps benefit from care in 
a dedicated pediatric intensive care unit (PICU).1 This knowledge, and the 
clinical apprehension that the actual patient retrieval was difficult and at 
times a weak link when a child was admitted to the PICU both from hospi-
tals inside and outside the Stockholm County, were the initial reasons for the 
department to set up a pediatric transport service. 
The knowledge and tradition of transporting children from the PICU in 
Stockholm by fixed wing aircraft was already available and originates from a 
decision to centralize pediatric cardiac surgery to the university hospitals in 
Gothenburg and Lund in the 1990’s. Today PETS provides transports around 
the clock, year-round on an acute, semi-acute and planned basis to and from 
Astrid Lindgren Children’s Hospital as well as between external hospitals in-
side and outside Sweden. In 2008 PETS expanded with a neonatal group for 
coverage of premature children as well as transports to and from the neona-
tal intensive care units (NICU) at Karolinska University Hospital. Children 
transported by Neo-PETS are not included in this thesis. 
Team composition includes a PICU consultant and a specialist anesthe-
sia or intensive care registered nurse with a minimum of three years experi-
ence in pediatric intensive care or pediatric anesthesia. When the retrieval is 
expected to be demanding with respect to transport duration, patient status, 
or if extensive medical equipment is needed, an experienced assistant nurse 
from the PICU can be added to the team.
The PETS team works as a mobile pediatric intensive care unit. The goal is 
to provide the same level of care during transport as in the PICU. Depending 
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on distance, availability and weather conditions a road ambulance or fixed-
wing air ambulance is used, more rarely a helicopter. The team helps to sta-
bilize the patient at the referring hospital, initiate PICU-therapies including 
vasoactive drugs, inhaled nitric oxide, perform interventions such as central 
and peripheral intravenous access and hemodynamic monitoring, intuba-
tion and mechanical ventilation. PETS performed 295 transports in 2018 and 
is the only specialized pediatric transport organization in Sweden. 
With an increased commitment and a growing organization there is a 
need for continuous development and research. Knowledge about outcomes 
after inter-hospital intensive care transports in Sweden is scarce and needs to 
be investigated. Approximately 60% of transports per year made by PETS are 
long-distance transports performed by air ambulance. In our transport envi-
ronment cabin pressure can be maintained at near atmospheric pressure (sea 
level cabin altitude) for a maximum of two hours before a fuel stop becomes 
necessary. For a routine one-hour transport, maintaining sea level cabin al-
titude requires 20% more fuel than normal consumption, or roughly 200 li-
ters of extra fuel. Thus, for flights ≥ 2 hours or for fuel economy, cabin pres-
sure is often maintained at a level corresponding to atmospheric pressure at 
7000 feet, or 2100 meters. Therefore, the effect of high altitude on critically ill 
children must be considered in pediatric transport medicine. 
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2  BACKGROUND
2.1 Centralization of pediatric intensive care
Medical reports from the 1990s state that centralization of intensive care for 
children to tertiary PICUs improves outcomes, both in decreased mortality 
and shorter lengths of stay (LOS).2-6 These reports contributed to the cen-
tralization of intensive care for children in many countries including Great 
Britain, France, The Netherlands, Australia and the US. In Sweden a study 
performed 1998-2001 showed that less than half of pediatric patients admit-
ted for intensive care in Sweden were cared for in a dedicated PICU, further-
more that LOS longer than 1 day correlated with increased mortality; 3.8%, 
4.4% and 5.9% for PICU, adult ICUs and adult university ICUs, respective-
ly.1 However, this study lacks a severity of illness score and therefore the au-
thors did not speculate on the risk-adjusted mortality in either adult ICUs or 
PICUs. They identified one group of children though, with short LOS and 
low mortality who are unlikely to benefit from transfer, and another group 
with significant mortality and longer LOS who might benefit from transfer 
to a dedicated PICU. 
Today Sweden is centralized with four tertiary PICUs, comparable to the 
situation in other European countries.7 The number of PICU beds is how-
ever relatively small in Sweden; 1.04 beds/100,000 inhabitants between 1-18 
years of age, which ranks Sweden seventeenth out of 23 countries studied in a 
European survey from 2002.8 A more recent study which compared 31 Euro- 
pean countries and the total number of intensive care beds in relation to pop-
ulation ranked Sweden number 30.9 National Swedish guidelines introduced 
in 2015 state that critically ill children under three years of age should be 
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With centralization of pediatric intensive care, it is inevitable that inter-
hospital transport of severely ill children and infants will increase and it is 
of uttermost importance that the transport function is easily accessible and 
safe without the actual transfer in itself resulting in a worse outcome for the 
patient.3, 4
2.2 The use of specialized pediatric transport teams
Until the late 1980s less than 10 articles had been published on pediatric criti- 
cal care transport.13 In 1986 the American Academy of Pediatrics (AAP) 
published a document titled “Guidelines for Air and Ground Transportation 
of Pediatric Patients”.14 This was a statement on the requirements of a spe-
cialized pediatric transport organization regarding personnel, equipment, 
mode of transportation etc. Studies from different healthcare systems in the 
1990s and early 2000s showed that inter-hospital transports of critically ill 
children by specialist pediatric transport teams tended to be associated with 
a lower incidence of technical and physiological adverse events as well as low-
er patient morbidity compared to when transports were performed by non-
specialist teams.15-18 
In 2006 a systematic review aiming to determine whether the use of spe-
cialist transport personnel improves patient hospital outcome in critically ill 
patients transported to higher specialized centers was published.19 Studies 
with only infants or neonatal patients were not included in the review. The 
authors reported that several studies which included pediatric patients15, 17, 18 
had documented improved patient safety during transport when specialized 
personnel were used, especially in the most severely ill patients, but that they 
had not looked at outcomes in the receiving hospitals. One exclusion criteria 
in the review was absence of a control group. Finally, six studies with a total 
of 4534 patients were included. One of the included studies concerned pedi-
atric patients.20 Out of six studies, only one study, which exclusively inves-
tigated adult patients, demonstrated a significant difference in mortality at 
the receiving hospital.21 The authors summarized that data at that time was 
insufficient to state if the use of specialist transport personnel improves out-
come at the receiving hospital when critically ill patients are transported to a 
more specialized center. 
In 2009 a prospective cohort study of consecutive children (n=1085) 
showed that the use of a specialized pediatric transport team was associated 
with improved survival rates after adjustment for illness severity compared 
to non-specialist teams.22 The specialized teams also experienced fewer ad-
verse events. There was a 38 times higher presence of one or more unplanned 
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event during transports performed by a non-specialized team compared to a 
specialized team (61.0% vs 1.6%). In this study referring hospitals, transport 
vehicles, command physicians and receiving hospital were the same for the 
whole study population and the only variable that differed was the transport 
personnel. The study provided strong evidence that the use of a specialized 
team can reduce mortality rates as well as adverse events, confirming the 
initial findings by Edge et al. in 1994 who demonstrated that children trans-
ported by specialized transport staff experienced fewer adverse events than 
those transported by non-specialized teams.18
In 2010 a national study from the United Kingdom was published includ-
ing 16875 children ≤ 16 years consecutively admitted to PICUs in England 
and Wales during 4 years, after being transported by either a specialist or 
non-specialist retrieval team.23 Primary outcome measures were mortality 
rates in PICU and LOS in PICU among survivors. Multivariable analysis 
showed significantly lower risk of death when patients were transported by 
a specialist team compared to non-specialist transport teams. Time spent in 
PICU was similar in both groups. The findings in this report supported the 
combination of centralization of intensive care for children and transports 
by specialized pediatric transport teams. 
There is an increasing body of literature that supports the premise that 
early goal-directed therapy improves outcome in many adult as well as pedi-
atric illnesses, such as septic shock, head injury and trauma.24-27 A prospec-
tive, single center, controlled before-and-after study, n=235, (patients aged 
1 month to 17 years), compared study groups prior to and after institution 
of a goal-directed resuscitation protocol for transport of critically ill child-
ren with Systemic Inflammatory Response Syndrome (SIRS) and SIRS-in-
duced shock.28 The results showed that patients in the two groups did not 
receive significantly different amounts of fluid resuscitation and only 5% of 
patients in the goal-directed therapy group received inotropic agents during 
transport compared to none in the non-goal-directed group. The goal-di-
rected therapy group had a shorter hospital LOS and required fewer initial 
ICU interventions. The authors noted that a combination of factors lead-
ing to overall improved quality of care and enhanced tissue oxygen delivery 
during transport led to the observed outcome differences.
2.3 Performance of a specialized pediatric transport team
At the Second National Interfacility Transport Medicine Leadership Confe-
rence, in 2000, the AAP called for standards for benchmarking and quality in-
dicators for transport organizations.29 This was also called for by Ramnarayan 
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in 2009, claiming that without robust indicators it would be impossible to 
monitor performance.30 In 2013 an article that summarized the meeting 
conclusions and consensus views from a National Consensus Conference 
held by The AAP Section on Transport Medicine (SOTM) was published.31 
It was stated that most programs have local quality indicators, but few have 
the opportunity to compare successes with others and that transport-specific 
benchmarks must be established.
To achieve consensus on appropriate neonatal and pediatric transport 
quality indicators among regional experts and practitioners of neonatal and 
pediatric retrieval in Ohio (US), and thereby permit comparisons among 
programs, a project was set up in 2011.32 By identifying candidate quality 
indicators through literature review and metrics currently in use by each 
transport program, consensus was achieved by nominal group technique. A 
national project was later set up and presented on behalf of the AAP SOTM 
in 2015.33
Initially 82 candidate metrics were considered; by using a so-called modi- 
fied Delphi technique ultimately 12 metrics achieved consensus as “very im-
portant” to transport: 1) Unplanned dislodgement of therapeutic devices, in-
cluding unplanned extubation 2) Verification of  tracheal tube (TT) place-
ment  3) Average mobilization time of the transport team 4) First-attempt TT 
placement success 5) Rate of transport related patient injuries 6) Rate of med-
ication administration errors 7) Rate of patient medical equipment failure 
during transport 8) Rate of CPR performed during transport 9) Rate of seri-
ous reportable event 10) Unintended neonatal hypothermia upon arrival to 
destination 11) Rate of transport related crew injury 12) Use of a standardi- 
zed patient care hand-off.  
Some of these 12 metrics will be reviewed in detail here:
2.3.1 Average mobilization time of the transport team 
Mobilization time of the transport team defined as: “from the start of the re-
ferral phone call to the transport team until the time the transport team is en 
route to the referral facility”. 
The team and vehicle activation and mobilization times are components 
which should always be minimized, but it has been argued that this criteri-
on says more about the organization of the transport team than the actual 
standard of care that the transport team will be able to give to the patient.34 
Nevertheless the response time, defined as the time from the start of the re-
ferral phone call to the time the transport team arrives at the referral hos-
pital, is a parameter which referring physicians understandably enough are 
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concerned about.35 The response time has also been pointed out by others to 
be an important quality indicator but rather difficult to measure since it is 
affected by many different factors such as geographical distances and condi-
tions, team and vehicle availability etc.36, 37 Long response times put the sick 
child at risk and authors have pointed out the importance of providing the 
local team at the referring hospital with active telephone guidance on con-
tinuing management until the transport team has arrived. This can be done 
both by the transport team and the receiving physicians.15, 30, 36, 37
The stabilization time at the referring hospital, that is, the time the trans-
port team requires to get the patient ready for transport is another retrieval 
time component that has been argued to measure the actual quality of care 
in critical care transport.34 The variation of median stabilization times which 
has been published is wide.15, 37-41 Reasons for this may be the number and 
magnitude of interventions performed on site before retrieval, taking into 
account that not only the intervention itself takes time but also the neces-
sary safety arrangements afterward such as measurement of blood gases and 
x-rays.41 
Stabilization is defined as the identification of those factors that, if not 
properly corrected, may lead to deterioration of the infant's condition during 
transfer. An adequate stabilization before transport lowers morbidity and 
improves the chances of survival. 
In a study of 2106 pediatric inter-hospital transports performed during 
a 2-year period, data were prospectively analyzed to examine the effects of 
patient- and transport related factors on the stabilization time and the ef-
fect of stabilization time on 24-hour PICU mortality.38 The length of stabili-
zation time itself had no negative impact on early PICU mortality, the only 
independent predictors being the Pediatric Index of Mortality Score (PIM2 
score)42, 43 and the number of major interventions required during stabiliza-
tion. Results also showed that only PIM2 score, number of major interven-
tions, and referral category (acute vs. non-acute transports) were significant 
variables affecting stabilization time. The numbers of urgent vital interven-
tions needed upon arrival at destination to tertiary PICU might also indicate 
inadequate stabilization during transfer.16, 30 
2.3.2 Rate of serious reportable events
It has been shown that the continuing process of critical incident reporting 
and review may reduce the number of adverse events during the transfer of 
critically ill infants.44 
From Canada, another modified Delphi study was published in 2014.45 
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The aim was to identify and evaluate indicators that represented significant 
events during pediatric transports, indicators which also would be relevant 
to future research in pediatric transport. An expert group picked out 57 in-
dicators of which 52 were determined to be relevant, 31 indicators from the 
transport literature and 21 new indicators, not previously identified in the 
literature. The authors claimed that with this large number of new indica-
tors future adverse events rates might differ from those previously reported. 
Some indicators presented by the Canadian group were identical to the Ohio 
list from 2011, but the Canadian list was much longer. The reason for this dis-
parity was, according to the authors, that their goal aimed for inclusiveness, 
whereas the Ohio group limited metric selection to 18–24 items and was fo-
cused on ease of application. 
These consensus-derived definitions45 of adverse events during inter-
hospital transports were adapted in a retrospective study from a single center 
pediatric, parameter driven, critical care transport provider using administ-
rative and clinical data of 8889 patients and published in 2016.46 The prima-
ry outcome was in-transit critical events, but unfortunately exclusively inter-
hospital transports contributed only to 72% of the total amount of transports 
(n=5672). The additional subjects were a mixture of scene calls and modified 
scene calls, making any interpretation of adverse events during the transport 
phase and identification of any associated factors to these events difficult. 
Authors concluded that the Transport Pediatric Early Warning Score was a 
poor predictor of critical events during transport. 
In 2014, the consensus quality metrics selected by the AAP SOTM were 
joined with the consensus metrics selected by the Air Medical Physician’s As-
sociation to create a database for data collection to improve critical care trans-
port: Ground and Air Medical qUality Transport Database (the GAMUT 
database). It is a free global resource for transport teams to track, report, and 
analyze their performance on transport-specific quality metrics by compar-
ing it to other programs.47 Participating air and ground critical care trans-
port programs submit aggregated data on a monthly basis. There is no indi-
vidual patient- or transport-level information. 
2.3.3 Rate of medication administration errors
The pattern of drug administration during inter-facility transports of criti-
cally ill children to a PICU has shown that a relatively small number of drugs 
are used frequently, but the total range of drugs that are used is large.48
In a study over 1 year from 1991 it was reported that 70% of patients 
transported by a combined neonatal and pediatric transport team were given 
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drugs; most commonly antibiotics (39% of patients), morphine (27%), an-
ticonvulsant drugs (24%), neuromuscular blocking agents (14%), respirato-
ry medications (including bronchodilators and surfactant) (12%), inotropes 
(11%) and sedatives (8%).49
The 2-year data published in 1996 from a combined pediatric and neo-
natal transport team, where 38% of neonates and 22% of pediatric patients 
were mechanically ventilated, showed that newborns received antibiotics 
and morphine more frequently than pediatric patients whereas anticonvul-
sant drugs and respiratory medications (including bronchodilators) were 
more commonly administered to pediatric patients.50
To investigate if vasoactive drugs could be safely administered via pe-
ripheral veins, a retrospective study was published in 2010 where the medi-
cal records of 1133 transports of neonates and children to intensive care units 
were reviewed.51 The risk for complications increased with higher medica-
tion doses (Dopamine 10 vs 15 microgram/kg/min) and longer duration of 
therapy. Authors concluded that prompt transitioning of vasoactive infu-
sions to a central venous line upon arrival at destination may lead to fewer 
complications but does not seem to be necessary before transport in transfers 
with a maximal duration of approximately four hours.
2.3.4 First-attempt tracheal tube placement success 
A multicenter retrospective study in 2015 of more than 7000 pediatric and 
neonatal transport patients investigated first-attempt tracheal tube place-
ment success.52 This showed a first-attempt intubation success rate for all in-
tubations of 64% and a spread between different transport programs of 35% 
- 87% first-attempt intubation success rate. Most teams consisted of an emer-
gency medical technician (EMT), a registered nurse (RN), and a registered 
respiratory therapist (RRT). The lowest figures occurred in programs with 
simulation only as the way to achieve initial intubation competency. The au-
thors concluded that understanding how certain transport programs achieve 
high performance is necessary in beginning to develop neonatal and pediat-
ric intubation best practices.
In a single center retrospective chart review from a hospital based neona-
tal/pediatric critical care transport team researchers aimed to determine risk 
factors for failed tracheal intubation in neonatal and pediatric transports, 
n=167.53 Patients were eligible if they were transported and intubated by the 
critical care transport team. The transport personnel responsible for trans-
port intubations were respiratory therapists. Patients were categorized into 
two groups for data analysis: 1) no failed intubation attempts and 2) at least 
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one failed intubation attempt. There were higher rates of intubation failure 
in transported neonates compared to transported pediatric patients. The risk 
seemed to be increased by the lack of benzodiazepine premedication and of 
a neuromuscular blocking agent. The presence of comorbid conditions was 
associated with a higher risk of tracheal intubation failure, regardless of age.
A multicenter retrospective study based on data from the GAMUT da-
tabase reported tracheal intubation attempts by critical care transport teams 
in 4.7% of a mixed (adult, pediatric and neonatal) cohort of 85704 transpor-
ted patients.54 Transfers included both pre-hospital and inter-hospital trans-
ports. First attempt tracheal intubation success was lowest in neonatal pa-
tients, better in pediatric patients and highest in adult patients. The success 
was highest when tracheal intubation was performed by adult critical care 
teams, also among pediatric patients. The presence of hypoxia and/or hy-
potension during intubation was lower when intubation was performed by 
adult teams than pediatric teams. The training level or experience of the per-
sonnel involved did not appear in the study and the success rates were low-
er than in-hospital success rates. Authors conclude that identifying factors 
affecting tracheal intubation success among skilled performers should influ-
ence best practice strategies for intubation.
2.3.5 Verification of tracheal tube placement  
In a prospective observational study during 18 months, 77 neonatal (34 pa-
tients) and pediatric (43 patients) patients were intubated by the respiratory 
therapist in a hospital based pediatric/neonatal transport team.55 Both rate 
of tracheal tube (TT) repositioning and on-scene time were examined. A 
post-intubation chest x-ray to verify correct TT-placement (mid-tracheal TT 
position) was performed in 85.7% of patients and showed malposition in 47% 
of cases, equally distributed between neonates and pediatric patients. Stabili-
zation time was significantly extended for the neonatal group if a post-intu-
bation chest x-ray was taken (average 33 minutes), but not for the older group. 
Authors conclude that post intubation chest x-ray is informative in this set-
ting and should be performed when feasible before the start of transfer even 
if the procedure may extend stabilization time.
Capnography is of great importance in confirming endotracheal tube po-
sition in critically ill children.56 Capnography readings might however, espe-
cially in pediatric patients, not always be reliable because of tube leakage. In 
these situations, the arterial CO2 pressure measured with a blood gas samp- 
le gives more information so that ventilator settings can be changed and the 
blood gas values normalized during transport.57 Analyzing the difference 
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in CO2 tension in mechanically ventilated neonates transported either on 
ground or in air (helicopter or fixed wing), showed no increased risk of ab-
normal CO2 tensions during air transports, but both hypercapnia and hypo-
capnia were common in both modes of transport.58  
The usability of blood gas analysis and its influence on therapeutic in-
terventions during inter-hospital pediatric intensive care transport were 
studied in a prospective observational study of 51 tests performed in 29 pa-
tients.57 Adjustment of FiO2 based on the blood gas results was required in 
45% of the patients before and during transport. The majority of interven-
tions were adjustments of the mechanical ventilation, but low potassium 
and hematocrit were also detected, and treatment initiated during transfer. 
Bhatia et al. showed that adjustment of mechanical ventilation was required 
in 30% of the patients on the basis of the blood gas results obtained before 
departure from the referring hospital.59
To document inter-hospital transport ventilation monitoring practices 
in severe pediatric traumatic brain injury patients, the use of end-tidal CO2 
(ETCO2) monitoring and blood-gas analysis were retrospectively studied in 
34 patients.60 Results showed that specialized transport teams used ETCO2 
monitoring significantly more often than non-specialized teams (90% vs 
23%), and if monitoring with ETCO2 was used, specialist teams were more 
likely to obtain a blood gas sample before departure (74 vs. 0 %).
2.3.6 Use of a standardized patient care handoff 
Patient handovers have been identified as safety risks by important health 
organizations. This has resulted in, for example, the  Swedish Association of 
Local Authorities and Regions (SKL) having prepared a document (SBAR) 
for structured patient handover. [Cited 2019 May 5]. Avaliable from https://skl.se/
halsasjukvard/patientsakerhet/sbarstruktureradkommunikation.748.html
A structured communication for patient handover is also important in inter-
hospital transports since care providers change.
A local quality improvement project introduced a standardized transport 
handover process that included parental input. The primary measure was 
provider satisfaction. Improvements in provider perception of communica-
tion and overall satisfaction with patient handovers for patients transpor-
ted by a specialized pediatric transport team and admitted both to general 
hospital wards and intensive care units was achieved.61 Authors point out 
that sustainability of this approach in work is unknown secondary to limi-
ted follow-up.
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2.4  Monitoring during pediatric  
 inter-hospital transportation
Today specialized pediatric transport teams act as an extended arm from 
the tertiary PICU to referring hospitals. They provide best possible care for a 
wide variety of disorders and deliver PICU resources both in skilled person-
nel and special PICU equipment to the referring hospital. 
The first prospective, randomized clinical trial in pediatric inter-facility 
transport was published in 2011.62 It was designed to determine the impact of 
improved blood pressure monitoring during pediatric inter-hospital trans-
port and the effect on clinical outcomes in patients with systemic inflamma-
tory response syndrome (SIRS) and moderate-to-severe head trauma. 94 pa-
tients 1-17 years were included. Patients in the intervention group received 
more intravenous fluid, had a shorter hospital stay and had less organ dys-
function. 
2.4.1 Near-infrared spectroscopy with special focus  
   on its use in a transport environment
Monitoring of oxygenation is important to ensure patient safety and the best 
possible patient outcome. Near-infrared spectroscopy (NIRS) is a noninva-
sive method for monitoring regional tissue oxygen saturation (rSO2).63 NIRS 
uses light of 700-1000 nm wavelength, a spectrum which most biological tis-
sues except for hemoglobin and cytochrome oxidase are rather transparent 
to, which allows for deep light penetration. A light emitting diode sends out 
the near-infrared light in an ellipse form to a detector, the photon penetrat-
ing depth in tissue is depending on the source-to-detector distance (mean 
depth is approximately 1/3 of source/detector distance),64, 65 Figure 1.
Oxygenated (HbO2) and deoxygenated (HbR) hemoglobin absorb near-
infrared light at different wavelengths, differences in absorbance between 
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HbO2 and HbR are detected by the sensor and the ratio between HbO2 and 
HbR is expressed as the regional oxygen saturation (rSO2) of the tissue. Since 
most blood in tissue is post arteriolar (approximately 3:1 venous to arterial 
blood) the rSO2 is an estimate of regional venous saturation.64, 66-68
 NIRS-monitoring is attractive in neonatal and pediatric practice not 
only because it is noninvasive, but also because the penetration of the sig-
nal into the tissue corresponds well with the anatomy of neonates, infants 
and children.66 Pediatric studies have demonstrated good correlation be-
tween cerebral regional oxygen saturation and jugular venous bulb satura-
tion.69 Anterior abdominal (splanchnic) rSO2 has shown strong correlation 
with gastric intra-mucosal pH as well as serum lactate and systemic venous 
oxygen saturation (SvO2) in children with congenital heart disease (CHD).70 
In this group of patients with risk for low cardiac output, splanchnic rSO2 
correlated better with systemic markers of oxygenation and perfusion such 
as serum lactate and SvO2 than did measurements over the renal bed. NIRS 
does not require a pulsatile flow for its measurements, which is considered 
advantageous in low-perfusion conditions and may help to identify patients 
at high risk for low cardiac output and adverse events.67, 70-72 There is an in-
ter-individual difference in NIRS values and therefore a trend monitoring 
approach has been recommended to minimize biological variation.64 In neo- 
nates rSO2 values change during the transition from fetal to extrauterine 
circulation and postnatal reference values at different ages have been pub-
lished.73, 74
Areas of use for NIRS monitoring today are many, for example in pediat-
ric and adult cardiac surgery (neuroprotection), in vascular surgery, in neo-
natal and pediatric intensive care and as a measure of the quality of cardio-
pulmonary resuscitation.75 NIRS has also been found to detect a decrease in 
cerebral rSO2 earlier than SpO2 from pulse oximetry in children undergoing 
anesthesia with periods of apnea during airway laser surgery and has been 
reported to be effective in detecting postoperative apnea in neonates.72, 76 In 
a review from 2014 authors concluded that despite the small single-center 
sample size and lack of randomization, recent studies have indicated a poten-
tial benefit in the utilization of NIRS in cardiac critical care.71 Nevertheless, 
more confirmatory studies are required to determine whether NIRS can be 
utilized to improve outcome with goal directed therapy.67, 71
Increasing interest has been drawn to the use of NIRS monitoring in the 
pre-hospital area since it is non-invasive and fairly easy to use, for example as 
a tool to assess traumatic brain injuries as well as need for blood transfusions 
in trauma patients.65, 77
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A systematic literature review was performed on NIRS methodology in 
December 2016, from the perspectives of NIRS-monitoring during trans-
ports in different vehicles. After inclusion and/or exclusion criteria had been 
considered five articles were finally selected for qualitative analysis. 
 
Figure 2 . PRISMA-diagram (Preferred Reporting Items for Systematic Reviews and Meta-
Analyses) of the selection process. The selection and collection of articles for the review 
included four steps: Identification, screening, eligibility and inclusion.  
Burillo-Putze et al. reported in 2002 that the NIRS-monitor did not in-
terfere with medical or aeronautical equipment.78 They reported that the 
NIRS monitor had a 4-hour battery life. They found that rSO2 remained rela-
tively constant at each altitude (0-5000 feet) in healthy volunteers.
Kikukawa et al. reported in 2008 that NIRS provides a sensitive method 
for measurement of pre-frontal oxygen status e.g. pre-frontal oxy-hemoglo-
bin concentration changes in helicopter pilots as a method for monitoring of 
cognitive demand during flight.79 The effects of vibration in the helicopter 
had no evident effect on the NIRS signals. 
In 2012, Wheaterall et al. who studied a NIRS monitoring system with 
availability of absolute oximetry monitoring, allowing reading without ini-
tial baseline calibration, found that 50% of NIRS-monitors were unable to 
provide monitoring outdoors without extra covering of the sensor, due to 
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ambient light exposure.80 Inside ground ambulances 100% of applied sensors 
provided monitoring, but interruptions resulting in loss of monitoring time 
were found in 6% of sensors. In helicopter transports, the sensor closest to 
the window provided successful monitoring more than 70% of the time in 86 
% of transports compared to 100% of transports for the inboard sensor, the 
reason being ambient light. Another challenge identified by the authors was 
NIRS-monitor battery power loss which abbreviated monitoring time. There 
was no signal loss due to patient movement or vehicle vibration. They found 
the screen display visibility to be reduced in very bright direct sunlight, but 
otherwise acceptable. 
Stroud et al. found that cerebral oxygen saturation in pediatric patients 
transported by helicopter may change with acute changes in altitude, espe-
cially in patients with respiratory illness and in need of high levels of respira-
tory support and at altitudes above 5000 feet.81 They concluded that cerebral 
oxygen saturation monitoring with NIRS may be a useful monitoring tool 
during inter-hospital helicopter transports of pediatric patients.
In their study from 2016, Valente et al. reported a decrease of at least 
20% in cerebral rSO2 in 50% of study patients (pediatric and neonatal pa-
tients) during transport in ground ambulance, helicopter and fixed wing air-
craft, but without any clinical deterioration, and therefore no interventions 
occurred.82 In the same study there was no significant association between 
patient positioning in transport vehicle and decreased cerebral oxygen satu-
ration during take-off or landing.
All studies had methodological shortcomings and the area most affected 
was the risk of selection bias. All studies also had a small sample size. Another 
shortcoming was the lack of diagnostic accuracy and measures of statistical 
uncertainty (e.g. 95% confidence intervals) which were not reported in any of 
the studies for the index test and only presented for the reference test in one 
study. 
Furthermore, there was great heterogeneity among NIRS-monitors that 
were used in the different studies. In the two studies with pediatric patients 
the same type of monitor was used (INVOS 5100C). This monitor is still 
manufactured and in clinical use unlike its precursor the INVOS 4100C 
which no longer is in clinical use but was studied in the article from 2002.78 
Generally, NIRS is widely used in different clinical settings, but like most 
medical technology it has not been developed for the pre-hospital environ-
ment with its special requirements on patient and vehicle movements or vi-
brations, the absence of medical equipment’s interference with flight instru- 
ments and vice versa, the influence of ambient light exposure, the duration of 
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battery life and weight of equipment to mention some.  
All five studies concluded that cerebral oxygen saturation monitoring 
with NIRS can be used in a patient transport environment. They also stated 
that NIRS may be a useful additional monitoring tool to already existing 
medical monitoring equipment during inter-hospital transports, but that 
larger sample sizes are needed and preferably also studies designed to guide 
therapeutic interventions. 
According to the Swedish Agency for Health Technology Assessment 
and Assessment of Social Services (SBU)83 there are 4 steps in the evaluation 
of diagnostic tests, with the last step being the question if outcome is better 
for patients undergoing the test compared with similar patients who did not 
undergo the test. This review showed that the research in this area cannot yet 
give an answer to that question. 
Searching the literature for NIRS utilization in a transport environment 
also showed that measurements in previous studies had been carried out 
by punctual monitor readings by the transferring personnel. There was no 
description of the electronically stored data being examined in an attempt 
to validate the method in a transport environment. Fairly few articles were 
found and only two concerned pediatric patients, meaning that the number 
of children examined is small; 17 patients transported by helicopter 81 and 24 
patients, of which 5 were transported in fixed wing aircraft, in the study by 
Valente et al.82
2.5 Severity of illness scoring systems  
 in pediatric transport
There is no validated, scoring system for evaluation of physiologic stability 
and risk assessment in relation to pediatric inter-hospital transports. There-
fore, several scoring systems appear in the pediatric transport research litera-
ture. For neonatal patients, two similar objective scoring systems have been 
validated for transport assessment.84-86
In order to evaluate the effect of the retrieval process on the validity of 
three common scores: pre-ICU PRISM, PRISM and PIM, a study was per-
formed in 2002.87 The conclusion was that PIM appeared to offer advantages 
over the other two scores in terms of being less affected by the retrieval pro-
cess and easier to collect, but that a recalibration of all scoring systems was 
needed. Since then the PIM score has been revised into PIM243 and PIM3.88
The Pediatric Index of Mortality (PIM2) score has been validated in the pe- 
diatric critical care population to predict mortality based on data collected 
within the first hour of admission to a PICU.42, 43 PIM2 describes how ill the 
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child was at the time when intensive care started. The observations to be re-
corded are those made at the time of first face-to-face (not telephone) contact 
between the patient and a physician from PICU, or a physician from a spe-
cialist pediatric transport team. PIM2 captures data of each variable mea-
sured from point of first contact until one hour post PICU admission. The 
first contact may be on retrieval.43 PIM2 was used in a large study involving 
specialized pediatric transport teams in England and Wales.23 
The Pediatric Risk of Mortality (PRISM) score has been frequently used 
in studies as a tool to assess the outcome of transported, critically ill children 
and as an indicator of the effectiveness of a specialized pediatric transport 
team on outcome.15, 18, 22, 89, 90 The use of pre-transport PRISM to estimate 
the requirements for intensive care or major interventions during transport 
has been discouraged since it may underestimate these needs.91
The Transport Risk Assessment in Pediatrics (TRAP) score's ability to 
contribute in appropriate placement for referred pediatric patients was eva-
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3  AIMS
The overall aim of this thesis was to evaluate the impact of inter-hospital 
transport on seriously ill children with special reference to short and long-
term outcomes and the effects of altitude. 
The specific aims were:
• To compare outcomes and resource use in children acutely admitted to 
PICU after transport with a specialized pediatric transport team to  
children acutely admitted through other sources
• To study short and long-term outcomes in children, acutely transported 
to PICU by a specialized pediatric transport team, in relation to age and 
risk score at admission. The hypothesis was that neonatal patients would 
be more resource demanding and have higher mortality rates than older 
patients
• To evaluate the need for an arterial blood gas in calculation of Pediatric 
Index of Mortality 2 (PIM2) and Predicted Death Rate (PDR) risk score
• To investigate the applicability of NIRS data electronically stored during 
transport in fixed wing air ambulance
• To examine the effects of high altitude on regional oxygen saturation 
during fixed wing air ambulance transports of critically ill children.
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4  MATERIAL AND  
 METHODS
4.1 Ethical considerations
This thesis was conducted according to the Helsinki Declaration (World 
Medical Association (WMA) Ethical Principles for Medical Research Involv-
ing Human Subjects 1964.96 All studies were performed after approval from 
the Stockholm Regional Ethical Review Board.97 In Study III The Stockholm 
Regional Ethical Review Board approved a nationwide study after consulting 
with the regional boards in Gothenburg and Lund (Dnr 02-483). For this co-
hort, extended ethical approvals were sought and subsequently granted (Dnr 
2007/1073-32, Dnr 2008/39-32, KI-Dnr 2009/1295-32, KI-Dnr 2016/2274-32).
Studies I-III are registry studies, the data contained no protected health 
information and there were no changes in patient care due to the database 
entry, which meant that the need for informed patient consent was waived. 
All data were presented at group level. 
In Study IV and Study V, participation has been voluntary, informed 
consent obtained and all participants have been guaranteed full confidenti-
ality.98, 99
This research project concerns children, and participating children have 
been critically ill and have therefore not been able to receive either oral or 
written information. Special care has therefore been taken to ensure that the 
children’s guardians have understood the information given and that they 
did not feel obliged to participate in this project.99, 100
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4.2 Overview of methods    
Study Design Study  
population
Number of  
participants
Statistical methods
I Retrospective 
register study
Children 0-18 
years, acutely 
transported to 
PICU 2008-2013 
by PETS 
221  
In control 
group: 3665 
patients
Chi-square statistics with 
Yate´s correction. Mann–
Whitney U-test.  Kaplan-
Meier method
II Retrospective 
register study
Children 0-18 
years, acutely 
transported to 
PICU 2008-2016 
by PETS
401 Chi-square statistics with 
Yate’s correction. Mann–
Whitney U-test.  Kaplan-
Meier method. ROC analy-
sis with Youden index
III Retrospective 
cohort
Children 0-16 
years, consecu-
tive admissions 
to PICU in 
Gothenburg 
2008-2010
990 Fisher’s exact test. Spear-
man ranking for evaluation 
of correlations.  
Mann–Whitney U-test.
IV Methodological 
study
Children 0-15 
years schedu-
led for air 
ambulance 
transport 2014-
2016
38 Friedman’s test with Dunn’s 
multiple comparison.  
Ansari–Bradley test. 
Smoothing by the Savitzky–
Golay filtering method.
V Prospective 
observational 
study
Children 0-15 
years sched-
uled for air 
ambulance 
transport 2014-
2019
39 Kruskal‐Wallis statistics with 
Dunn’s multiple comparison 
test. Friedman’s test with 
Dunn’s multiple comparison 
tests. Wilcoxon signed-rank 
test was used for the com-
parison of column medians 
to a hypothetical value.
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Astrid Lindgren Children’s Hospital after an acute inter-hospital transport 
by a specialized pediatric transport team.
4.3.1.2 Cohort design
All patients, between 0-18 years of age, acutely transported to the PICU at 
Astrid Lindgren Children’s Hospital by the department's specialized trans-
port team 1 January 2008 - 31 December 2013 were retrospectively enrolled. 
In Study I a control group of all other acutely admitted PICU-patients during 
the same time period but through other routes was also created. The two 
groups were compared regarding background data, length-of-stay (LOS) 
in PICU, Predicted Death Rate (PDR), PICU-mortality and 30-day mortal-
ity. Markers of resource use in PICU that were extracted were: invasive ven-
tilation, length of ventilation and PICU specific therapies such as vasoac-
tive support, inhaled nitric oxide and continuous renal replacement therapy 
(CRRT).
An extended data collection was done including acutely transported pa-
tients to the PICU at Astrid Lindgren Children’s Hospital by the department’s 
specialized transport team during 1 January 2014 – 31 December 2016. This 
larger cohort 1 January 2008 – 31 December 2016 formed Study II.
4.3.1.3 Data source and collection
Data from a Patient Data Management System (PDMS) where all patients 
admitted to the PICU at Astrid Lindgren Children’s Hospital are registered 
was used. Transported patients were identified through the transport unit’s 
transport register by unique personal identification numbers that follows 
each Swedish citizen from birth to death.
Admission data, consisting of admission and discharge dates, including 
the Paediatric Index of Mortality2 (PIM2) score and its derived PDR, LOS 
and PICU diagnosis were collected in PDMS. Data is automatically collected 
from medical bedside devices into PDMS. Hence, information on ventilatory 
support including ventilatory days and PICU specific therapies could be col-
lected from PDMS.
All patients are given a PICU diagnosis based on the primary reason for 
PICU admission. This data, which is based on the International Classifica-
tion of Diseases version 10, Swedish Edition (ICD-10-SE) was also collected 
from PDMS and entered into the study database. Patients were grouped ac-
cording to the different diagnostic groups.
In Study II, the study cohort was divided into subgroups based on patient 
age and PDR at admission.
The latest version of the Paediatric Index of Mortality (PIM3) was adopted 
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in Sweden in October 2016, patients transported October - December 2016, 
had their PIM3 recalculated to PIM2. Recalculations were done in a separate 
excel PIM2-calculator and checked by using a free online PIM2 calculator 
from SFAR – Société Française d'Anesthésie et de Réanimation [Cited 2017 
April 15] (https://sfar.org/scores2/pim22.php).
4.3.1.4 Data quality assurance
All data from PDMS was received in electronic form and converted into an 
Excel spreadsheet (Microsoft Excel 2010). All entered data were both manu-
ally and electronically checked for errors. Erroneously included admissions 
(age>18, date of birth inconsistent with date of admission) were excluded. 
Temporary identification numbers were identified in the hospital charts for 
information of their date of birth, which was then entered into the study da-
tabase. If no valid personal identification number was found, patients were 
excluded in Study II, since they could not be followed up in the national data 
base.
Dates for PICU admission and discharge were collected. Patients with 
a LOS in PICU less than one hour were manually checked in the hospital 
charts for admission time and discharge. If incorrect, the correct time was 
then entered into the database. After the last corrected admission, an addi-
tional number of ten admissions were checked. When ten admissions in a 
row showed consistent with data in hospital charts, the control was stopped. 
Patients with the longest LOS were checked against hospital charts in the 
same way, and correct admission and discharge time was entered into the 
database. After the last correction an additional number of ten admissions 
were checked. When ten admissions in a row showed consistent with data in 
hospital charts, the control was stopped.
All patients with PIM2 data recorded as systolic blood pressure = 0, as an 
indicator of cardiac arrest, were double checked in hospital charts and cor-
rected and PIM2 recalculated if not found to be correct. This was also done 
for patients where pupillary reaction to bright light was recorded = No. 
4.3.1.5 Data from national registers
The 30-day mortality data was provided through the Swedish Intensive Care 
Register. The long-term mortality rate for the transported group was ob-
tained from the population registry (Swedish Tax Agency), by the unique 
personal identification numbers. 
4.3.1.6 Long-term mortality calculations (Study II)
Long-term mortality was calculated using the last registered admission to 
PICU during the study period. Mortality calculations were done using the 
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Kaplan-Meier method (Study I and II), and patients were grouped both ac-
cording to age and PDR at admission. A 30-day cut-off was used to define 
late death. To describe long-term mortality, we calculated conditional sur-
vival, defined as observed survival if the patient survived the first 30 days 
after admission to PICU. The reliability for predicting PICU, 30-day and 90-
day mortality with PIM2 was tested by calibration of ROC curves at these 
time intervals. 
4.3.2 Study III
4.3.2.1 Patient population
1793 consecutive admissions (1255 patients) aged 0-16 years. An arterial 
blood-gas sample was found in 990 admissions who then formed the study 
group.
4.3.2.2 Cohort design
This was a subset of data from a national prospective study from 3 PICUs in 
Sweden.101 Patients 0-16 years, consecutively admitted to the PICU at Queen 
Silvia Children’s Hospital, Gothenburg, Sweden 1 January 2008 – 31 Decem-
ber 2010 were enrolled. All admissions were grouped according to Austra-
lian New Zealand Paediatric Intensive Care (ANZPIC) registry. Patients with 
an arterial blood gas sample present at admission, regardless of diagnostic 
group, formed the study group. Two separate cohorts were identified based 
on PICU admission diagnosis. One with an admission diagnosis “Respirato-
ry” and one called “Non-respiratory” with all other admissions. 
4.3.2.3 Data collection
PIM2 and its derived PDR were recalculated in patients with an available 
arterial blood gas sample at admission, omitting the PaO2/FiO2 ratio, and 
the risk scores with and without the PaO2/FiO2 ratio present were thereafter 
compared. The difference in predictability between the respiratory and non-
respiratory groups was compared with the PaO2/FiO2 ratio omitted from the 
PIM2 calculation.
4.3.3 Study IV and V
4.3.3.1 Patient population
Study IV: 38 pediatric patients, age range newborn - 4 years, scheduled for in-
ter-hospital air ambulance transport were enrolled by convenience sampling. 
Study V: 39 pediatric patients, age range newborn - 4 years, median age 
12 days, who were scheduled for inter-hospital air ambulance transport were 
enrolled by convenience sampling. 
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4.3.3.2 Study design
The study population consisted of 38 (39 patients in Study V) seriously ill pe-
diatric patients scheduled for inter-hospital transport in air ambulance be-
tween January 2014 and September 2016, convenience sampling (until Janua-
ry 2019 in Study V). Monitoring began at the referring hospital and ended 
at the receiving hospital. Patients were transported in Beech Super King Air 
200 or Cessna Citation II 550 air ambulances. 
 
4.3.3.3 Equipment and procedures
Near-infrared spectroscopy (NIRS) with INVOS-5100C (Covidien, Mans-
field, MA, USA) was used to monitor regional oxygen saturation (rSO2). In 
all patients a cerebral (rSO2-C) and an abdominal (rSO2-A) NIRS sensor 
were applied, Figure 4. The probes had two light paths with an emitter/diode 
spacing of 30-40 mm and a light penetrating depth of 20-40 mm.
Figure 3. Interior photo 
from the air ambulance 
during Study V. The PhD 
student is keeping track  
of the study protocol.  
The study patient is  
mechanically ventilated.
Figure 4 . Locations of 
cerebral and splanchnic 
sensors.  
Down loaded  from 
Google, https://www.
spiedigitallibrary.org/
journals/journal-of-
biomedical-optics/vol-
ume-21/issue-09/091306/
Review-of-splanchnic-
oximetry-in-clinical-
medicine/10.1117/1.
JBO.21.9.091306.full
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All patients were also monitored with standard hemodynamic monitor-
ing, pulse oximetry, body temperature, respiratory rate and evaluation of 
level of sedation by Comfort-B.102 Recorded values were noted in the study 
protocol before flight (base-line), during flight with cabin pressurization cor-
responding to ≥ 5000 feet and after flight. No clinical care decisions based on 
values presented on the INVOS monitor were allowed.
rSO2 data were electronically stored by the INVOS monitor during trans-
port and extracted and analyzed off-line. Data were downloaded to MS Ex-
cel 2010. For each patient zero values and unreliable values, meaning values 
which remained steady at a detection level of 15% (“floor-effect”) were iden-
tified for both sensors during the entire monitoring sequence and removed 
before noise reduction of the signal. 
In Study IV the Savitzky–Golay algorithm of smoothing and differentia-
tion of data by simplified least square procedures (least-square fitting) was 
applied to the unprocessed signal data to perform noise reduction.103 The 
2nd order of smoothing polynomial in combination with the optimal num-
ber of neighboring points were determined to eliminate noise without de-
tailed information being erased. MATLAB®, MathWorks (Natick, MA, USA) 
was applied for the implementation and analysis of the Savitzky–Golay fil-
ters. 
 
Figure 5. The variability in the signal was investigated by using the absolute difference 
between 2 adjacent readings. 5A: Unprocessed data, 5B: 3 neighbors, 5C: 5 neighbors and 
5D: 20 neighbors.
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which remained steady at a detection level of 15% (“floor-effect”) were iden-
tified for both sensors during the entire monitoring sequence and removed 
before noise reduction of the signal. 
In Study IV the Savitzky–Golay algorithm of smoothing and differentia-
tion of data by simplified least square procedures (least-square fitting) was 
applied to the unprocessed signal data to perform noise reduction.103 The 
2nd order of smoothing polynomial in combination with the optimal num-
ber of neighboring points were determined to eliminate noise without de-
tailed information being erased. MATLAB®, MathWorks (Natick, MA, USA) 
was applied for the implementation and analysis of the Savitzky–Golay fil-
ters. 
 
Figure 5. The variability in the signal was investigated by using the absolute difference 
between 2 adjacent readings. 5A: Unprocessed data, 5B: 3 neighbors, 5C: 5 neighbors and 
5D: 20 neighbors.
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The principle of signal smoothing:104
1) A data interval is selected
2) A low-order polynomial function is fitted to the data within this interval
3) The experimental point is replaced by the polynomial predicted one at 
the center of the interval
4) The process is repeated after shifting the window ahead by one sampling 
interval
In Study V a cerebral - splanchnic ratio (rSO2-C/rSO2-A) for each patient 
at baseline and at altitude ≥ 5000 feet was calculated to further evaluate dif-
ferences between cerebral and splanchnic oxygenation.
4.4 Statistical analysis
4.4.1 All studies
Continuous data are reported as medians and interquartile range (IQR). 
Categorial data are expressed as median (range) or frequencies (proportions). 
A p-value ≤ 0.05 was considered statistically significant and reported p-val-
ues were from two-sided tests. Statistical analyses were undertaken using MS 
Excel (Microsoft Corporation, Redmond, Washington, USA) and Graph-Pad 
prism 5.04 (GraphPad Software Inc., La Jolla, CA, USA).
4.4.2 Study I and II
Survival was depicted by the Kaplan-Meier method. Classified data from two 
independent populations were compared using Chi-square statistics with 
Yate´ s correction. Two independent groups of samples were compared using 
the Mann-Whitney U-test. SMR and its 95% confidence intervals were cal-
culated as given by Liddell.105 The maximum effectiveness of PDR was evalu-
ated by ROC analysis with Youden index in Study II.106
4.4.3 Study III
Correlations were assessed by the Spearman rank correlation test. Two inde-
pendent groups of samples were compared using the Mann-Whitney U-test. 
Classified data from two independent populations were compared by Fisher’s 
exact test. SMR and its 95% confidence intervals were calculated as given by 
Liddell.105 Bias was calculated as outlined by Sheiner and Beal.107 The vari-
ance ratio test was used for the comparison of the variability of data in two 
populations. 
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4.4.4 Study IV
Several dependent populations were compared with Friedman’s test with 
Dunn's post-test. The equality of scatter in two populations was performed 
by the Ansari–Bradley test. The NIRS curves were smoothed by the Savitz-
ky–Golay filtering method.103
4.4.5 Study V
Several independent populations were compared with Kruskal‐Wallis sta-
tistics with Dunn’s post-test. Coefficient of variation was compared with the 
Friedman’s test with Dunn’s post-test. The Wilcoxon signed‐rank test was 
used for the comparison of column medians to a hypothetical value. 
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5  SUMMARY OF RESULTS
Only main results are presented. For detailed results, please see the full-text 
manuscripts enclosed at the end of this book.
5.1 Study I
In Study I we investigated outcomes of patients acutely transported to PICU 
by a specialized pediatric transport team. Transported patients were com-
pared to a control group of children acutely admitted to the same PICU over 
the same 6-year period but through other routes. Transport distance, mode 
of transport and diagnoses in relation to mortality were also studied. The 
main findings are presented in Table 2.
We found that transported children were younger, sicker, had a longer 
LOS in PICU and needed more of PICU specific therapies than other acute 
admissions. Transport itself, assuming an experienced and suitably equipped 
transport team, did not increase risk of death, which was evidenced by a simi- 
lar Standardized Mortality Ratio (SMR) in both groups. We also found that 
long transport distances were not associated with a higher mortality risk. 
An incidental finding of PICU mortality, even though not statistically 
significant, being especially high in neonates < 28 days, evoked the questions 
that led to Study II. 
Figure 6 . The survival curve 
indicates that the youngest 
patients in a larger proportion 
died earlier on, but over time 
the two curves seem to ap-
proach each other.
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Patient  
characteristics
Acutely  
Transported
Acutely admitted  
by other routes
p-value
No. of patients N=221 N=3444
Age, median (IQR) 0.40 years (0.08-1.59 
years)
1.32 years (0.16-6.70 
years)
< 0.0001
No. of patients ≤ 30 days 58 (26.2%) 667 (19.4%) 0.0164
No. of patients < 1 year 141 (63.8%) 1560 (45.3%) 0.0004
Diagnostic Group
Respiratory 102 (46.1%) 901 (26.2%) < 0.0001
Neurological including 
convulsions
11 (5.0%) 537 (15.6 %) < 0.0001
Trauma and poison 10 (4.5%) 379 (11.0%) 0.0035
Infection including 
sepsis
19 (8.6%) 126 (3.7%) 0.0005
Malformations 25 (11.3 %) 367 (10.9%) 0.8465
Certain perinatal  
conditions
7 (3.2 %) 98 (2.8%) 0.9441
Resource use in PICU
Mechanical ventilation 171 (77.4%) 1193 (34.6%) < 0.0001
Duration of mechanical 
ventilation, median (IQR)
93.8h (41.5 – 201.8h) 44.5h (13.7 – 113.5h) < 0.0001
Inhaled Nitric Oxide 
(iNO)
26 (11.8%) 103 (3.0%) < 0.0001
Vasoactive drugs 54 (24.4%) 271 (7.9%) < 0.0001
Renal replacement 
therapy (CRRT)
6 (2.7%) 49 (1.4%) 0.2127
Extracorporeal mem-
brane oxygenation 
(ECMO)
13 (5.9%) 65 (1.9%) 0.0002
Time in PICU, median 
days (IQR)
4.24 (1.81 – 8.80 days) 1.06 (0.60 – 2.97 days) < 0.0001
Patients outcome
PDR, median (IQR) 5.58% (1.44 – 11.49) 1.39% (0.76 – 4.02) < 0.0001
Expected mortality 24 (10.9%) 174 (5.0%) 0.0004
PICU mortality 15 (6.8%) 85 (2.5%) 0.0003
30-day mortality 19 (8.6%) 116 (3.4%) < 0.0001
SMR (95 % CI) 0.618 (0.346 to 1.02) 0.489 (0.390 to 0.604) 0.2832
Table 2 . Patient characteristics and outcomes for patients acutely transported by the spe-
cialized pediatric transport team and for patients acutely admitted through other routes to 
the PICU. Selected diagnoses are included in the table, for all diagnoses and characteristics 
please see the full-text manuscript.
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5.2 Study II
In Study II age-related differences regarding short-and long-term survival, 
PICU-LOS and resource use during transport and in PICU among trans-
ported patients were evaluated. We also investigated the impact of PIM2 and 
PDR at admission on survival. 
Median follow-up time for the entire cohort was 3.4 years (IQR 1.7-6.3 
years, range 0-10.2 years) and for survivors during the study period 4.4 years 
(IQR 2.3-6.7 years, range 0-10.2 years). The median PICU-LOS was 3.8 days 
and similar for all age groups. Mechanical ventilation was high during trans-
port (71.9%) and in PICU (78.3%), there was no difference in use between age 
groups. Vasoactive support was used during 12.2% of all transports and in 
25.2% of all PICU admissions. Inhaled nitric oxide (iNO) and Extra Corpo-
ral Membrane Oxygenation (ECMO) therapy were more common in neo-
natal transports, in other respects we found no difference between neonates 
and older children regarding resource use. 
Immediate survival after PICU treatment was 91.6% in neonates, 92.3% 
in infants (>28 days-1 year), 97.2% in children >1-4 years and 94.4% in chil-
dren >4 years. Of all PICU deaths, 61.5% occurred during the first week of 
PICU treatment. 
  
Figure 7 . PICU mortality in relation to A: age at admission and B: PDR at admission.  
Observed PICU mortality was lower than expected for the entire cohort with a SMR of 0.59 
(95%CI: 0.383-0.860) p<0.004.
Black bar=Expected mortality, White bar=Observed mortality.
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Almost 70 % of late deaths occurred within the first year (54% within the 
first 6 months) and over 90% within the first three years. Of all deaths with-
in the first year 47.8% were in infants (>28 days-1 year) and 34.8% of deaths 
occurred in the age group >1-4 years. In the neonatal group no deaths oc-
curred after discharge from intensive care. Log-rank tests (Mantel-Cox) 
comparing Kaplan-Meier curves of long-term survival and age groups at ad-
mission showed no statistically significant difference.
When long-term mortality was investigated in relation to PDR, the ma-
jority, 63.6% of all late deaths occurred in PDR group 0-10% and over 60% of 
them died within the first year, 30% of deaths during the first year occurred 
in PDR-interval >10-25%. Thereafter no deaths occurred in this group dur-
ing the study period. In PDR >50%, half of the group died at PICU and one 
more patient died within the first 30 days. Thereafter no additional deaths 
occurred in this group, which resulted in an overall survival of 43.7% and a 
conditional 5-year survival of 100%, Table 3.
Figure 8 . The 30-day mortality follow-up in relation to, A: age at admission and  
B: PDR at admission, showed a SMR of 0.68 (95%CI: 0.457-0.967) p<0.03 for the entire  
cohort. SMR in children > 4 years 1.05 (95%CI: 0.383-2.281), p=0.98.  
Black bar=Expected mortality, White bar=Observed mortality.
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Group n PICU 
survival, n 
(%)  
30-day 
survival, n 
(%)
1-year 
survival, n 
(%)
5-year 
survival, n 
(%)
5-year 
conditional 
survival, %
0-28 days 84 77 (91.6) 76 (90.5) 74 (88.1) 74 (88.1) 97.4
>28 days- 
1 year
155 143 (92.3) 143 (92.3) 132 (85.2) 131 (84.5) 91.6
>1-4 years 107 104 (97.2) 103 (96.3) 95 (88.8) 91 (85.0) 88.3
>4 years 55 51 (94.4) 49 (89.1) 47 (85.4) 43 (78.2) 87.8
PDR 0-10% 293 288 (98.3) 284 (96.9) 271 (92.5) 263 (89.8) 92.6
PDR >10-
25%
52 46 (88.5) 48 (92.3) 41 (78.8) 41 (78.8) 85.4
PDR >25-
50%
40 33 (82.5) 32 (80.0) 29 (72.5) 28 (70.0) 87.5
PDR >50% 16 8 (50.0) 7 (43.7) 7 (43.7) 7 (43.7) 100
Table 3. Survival numbers for 4 different age categories and 4 different PDR categories 
after PICU treatment, 30-day mortality, 1-and 5 years later. Conditional survival = Observed 
survival if the patient survived the first 30 days after admission to PICU.
There was a high mortality rate in patients with multiple transports, 36% 
of these patients died during the study period, a majority of those deceased 
died outside PICU.
5.3 Study III
The influence of arterial blood gas (ABG) data (i.e. the PaO2/FiO2 ratio) on 
the estimation of the PIM2 score and the Probability of death (%) was in-
vestigated in Study III. 1793 consecutive admissions (1255 patients) aged 
0-16 years were enrolled. An ABG was found in 990 admissions which then 
formed the study group. Patients were grouped as respiratory and non-respi-
ratory as an attempt to investigate any important differences in relation to 
diagnoses. 
In the non-respiratory group, there was close agreement between pre-
dicted and true Probability of death (%) even though the PaO2/FiO2 data 
was omitted. For the respiratory group, important deviations of the predic- 
ted Probability (%) from the true Probability (%) occurred for PIM2 score ex-
ceeding –2.20 (Probability of death > 10%). The difference in Probability (%) 
estimated from PIM2 with and without PaO2/FiO was significantly larger in 
the respiratory group than in the non-respiratory group (p<0.0001), Figure 9. 
In patients with Probability >10%, estimated without PaO2/FiO2 data, 
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42
43
the differences in Probability (%) with and without PaO2/FiO2 data were 
3.161 (median value; IQR: 1.477 to 6.459) units in the non-respiratory group 
and 4.397 (median value; IQR: 2.802 to 9.251) in the respiratory group, re-
spectively. The variability in the respiratory group was significantly larger 
(p<0.0001). The SMR was slightly, albeit not statistically significantly over-
estimated, by not including PaO2/FiO2 data in the calculation of the PIM2 
score.
Patients with the PaO2/FiO2 ratio available had a statistically significant 
higher Probability (%) than patients without the PaO2/FiO2 ratio available at 
admission, 1.388% (0.8361–4.049) and 0.7509% (0.4064–2.179) respectively, 
p < 0.0001. 
 
Figure 9 . Difference in the Probability of death (%) with and without arterial blood gas data 
between A: respiratory and B: non-respiratory groups versus Probability (%) without arterial 
blood gas data.
5.4 Study IV
The collected data during transport were downloaded after the transport and 
cleared for artefacts, by removal of “zero-values” and “floor-effect” values, 
defined as values which remained steady at the lowest noted detection level of 
15%, and thereafter smoothened by a noise-reduction algorithm. The Savitz-
ky-Golay filtering technique, using smoothing and differentiation of the sig-
nal by least square procedures was applied on the NIRS-signal to reduce sig-
nal interference and thereby increase the ability to distinguish between real 
and artefact-related events. The 2nd order of smoothing polynomial in com-
bination with the optimal number of neighboring points was determined to 
eliminate noise without loss of detailed information.
The signal noise decreased drastically when the numbers of neighbors 
was increased up to values of 20. A further increase only seemed to affect the 
noise level to a minor extent. However, visual inspection of the NIRS signal, 
after the Savitzky-Golay smoothing, showed that a further increase of the 
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number of neighbors beyond 20 still implied a considerable improvement of 
the signal, Figure 10. Tests revealed that fewer neighbors must be used when 
the study time frame was shortened. Significant distortions and loss of fea-
tures of the data such as peaks and width were seen when the signal was 
smoothed with too many neighbours. Too few neighbors resulted in signals 
with too much noise.
  
Figure 10 . The unprocessed data as well as the effect of smoothing with 20, 50 and 100 
neighbors respectively are presented with a total time frame of 13.5 hours. There were still 
details in the signal when 100 neighbors were used, but much less noise. The unprocessed 
data in the shown example consisted of more than 8000 readings.
5.5 Study V
We compared regional oxygen saturation in cerebral and splanchnic tissue 
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Among patients with a ratio < 1 at baseline, all but 2 had an increased ra-
tio closer to 1 at altitude ≥ 5000 feet. We found no association between age, 
breathing support or diagnosis in patients with a ratio < 1. 
In patients with cyanotic heart malformations the rSO2-C value at al-
titude ≥ 5000 feet decreased compared to baseline in 6 of 9 patients and 
rSO2-A decreased in 4 patients. In the subgroup of cyanotic patients 78% 
had a rSO2-A value < 60% at baseline compared to only 30% of non-cyanotic 
patients. Different patterns of reacting to altitude was visualized by data 
smoothing, Figure 11.
Figure 11. Different patterns of reacting to altitude in three different patients. rSO2-C was 
higher, at the same level and lower than rSO2-A. The rSO2 curves were smoothed with the 
Savitzky–Golay filtering method (20 neighbors were used).
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6  DISCUSSION
6.1 Summary of main findings
In this thesis we show that inter-hospital transport of seriously ill children, 
provided that the transport team is skilled and suitably resourced, does not 
increase the risk of death irrespective of transport distance. Moreover, we 
found that there was no difference in outcomes by age-groups at admission, 
specifically neonates versus non-neonates, as hypothesized. On the other 
hand, patients with multiple transports had a worse long-term outcome than 
patients transported once. We found that arterial blood gas analysis should 
be performed in PICU patients with a respiratory diagnosis where a high ill-
ness severity is suspected, or if otherwise considered clinically appropriate. 
Furthermore, that arterial blood gas analysis can be omitted in other patients 
without loss of accuracy of the PIM2 and Probability of death (%) score. We 
have demonstrated that the Savitzky–Golay filtering technique constitutes a 
feasible way to facilitate interpretation of changes in the near-infrared spec-
troscopy (NIRS) signal, and thereby regional oxygen saturation, in relation 
to physiological changes in patients and events during transport. Thus, when 
using the technique during air-ambulance transports, a decrease in cerebral 
and splanchnic oxygen saturation at altitude ≥ 5000 feet was observed, where 
cerebral oxygen saturation was preserved more than splanchnic oxygen satu-
ration in most patients. 
6.1.1 Study I and II
In more detail, we have performed the first study on pediatric critical care 
transports in Sweden, reporting outcomes of transported children admitted 
to a Swedish PICU (Study I). We found a higher predicted death rate (5.58% 
vs 1.39%), 30-day mortality rate (8.6% vs 3.4%), longer LOS (4.24 vs 1.06 days) 
and increased use of PICU specific therapies in transported children. Never-
theless, SMR was similar in the two groups. All retrievals were led by a pedi-
atric intensive care consultant, since this is our routine, a team model which 
is less common for example in the US even for specialized pediatric trans-
port teams.108, 109 In 2015 Swedish professional societies agreed on a national 
referral strategy stating that critically ill children < 3 years should be trans-
ferred to a PICU.10 In the same manner it was stated that transports of criti-
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cally ill children < 3 years from general ICUs to PICU should be undertaken 
by teams where both the physician and the nurse are experienced in pediat-
ric intensive care. 
Even though studies similar to ours have previously been published from 
other regions of the world,22, 23, 110 it was our conviction that the conditions 
of Swedish pediatric inter-hospital transports needed to be mapped. To be 
kept in mind is not only demographic differences, long geographic distances 
and challenging climate conditions, but also the rather sparse availability of 
pediatric intensive care beds in Sweden, which can be a limited resource es-
pecially during certain periods such as infection season.1, 8, 9 In Sweden ter-
tiary pediatric intensive care has been centralized to 4 centers and pediatric 
intensive care transports are growing by number. It is therefore important to 
ensure high quality of the service where specialized pediatric teams offer the 
most qualified method of transport, but also to find areas that need to be im-
proved. Are the right patients being transferred? Are they being transferred 
in a safe way? Are their outcomes comparable to other PICU-patients?
Consequently, it is important that children who benefit most are trans-
ported to PICU. In Study I, we found that transported children were sicker, 
younger and stayed longer in PICU. In addition, the rate of respiratory failure 
was high with 77% mechanically ventilated admissions in the transported 
cohort, compared to 34.6% in the non-transported, in all indicating that the 
right patients were transported. We could also show that the transport per se 
does not increase the risk of death irrespective of transport distance.
In Study II we have presented some unique data that has not been report-
ed previously, i.e. long-term survival outcome of acutely transported PICU 
admissions. The 4.4-year median follow up (range 0-10.2 years) for survivors 
is a significantly long period of follow up and provides a useful perspective 
on longer term outcomes of this cohort. The finding that patients transported 
multiple times have a worse long-term outcome has not been shown be-
fore. We found that cumulative mortality almost doubled within the first 6 
months after PICU discharge, 6.5% vs 12.7% (n=26 at discharge, n=7 between 
PICU and 30 days and n=18 between 30-days and 6 months) and was 15.7% 
after 3 years. This is in line with previous reports where mortality appears 
to substantially increase after PICU discharge in a general pediatric intensive 
care population.1, 101, 111 Survival over time is visualized by the Kaplan-Meier 
plot where the transported cohort is compared to the normal pediatric popu-
lation in Sweden. 
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Patients in our cohort showed both high short- and long-term mortal-
ity. Mechanical ventilation, number of ventilator days, use of vasoactive sup-
port and PICU LOS have been shown to be associated with poor long-term 
functional outcome.111 These indicators of severity of illness were all com-
paratively high in our cohort as compared to other PICU patients (Study I). 
A potential association between inter-hospital transport from an intensive 
care area and PICU mortality has previously been shown, and a majority of 
patients in Study I and II were transferred from adult ICUs.112 Our hypoth-
esis that neonatal outcomes would be worse than for older children, was not 
proven correct. There was no mortality in this age group after ICU discharge, 
resulting in a conditional 5-year survival of 97.4%. Overall, medical vulner-
ability of transported children who survive critical illness in a PICU is sig-
nificant. Therefore, assessing mortality at discharge from PICU alone must 
be challenged as it might not correctly present all consequences of critical ill-
ness in this cohort. The model of using the performance of PIM scoring in 
predicting 30 and 90-day mortality might be useful for this purpose. 
6.1.2 Study III
In Study III we analyzed the impact of an arterial blood gas sample (i.e. the 
PaO2/FiO2 ratio) on the PIM2 and the derived probability of death in relation 
to diagnostic groups at admission. The rationale behind was an awareness 
that emerged when examining data from Study I, that is an arterial blood gas 
sample was missing in many of the PIM2 scores. Since PIM2 assumes a miss-
ing PaO2/FiO2 value to be 0 in the calculation of the score and nearly 50% of 
transported patients had a respiratory diagnosis and furthermore nearly 80% 
of all transported patients were mechanically ventilated we formulated the 
Figure 12 . Comparison of survival 
over time in transported patients 
and in the normal pediatric popu-
lation. Based on Statistics Sweden 
“Death rate per 1000 children 
in Sweden”, SMR 114 (95% CI 
86-151).
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research question. The problem with missing arterial blood gas sampling has 
been addressed by other investigators and the possibility to estimate PaO2/
FiO2 from a SpO2/FiO2 value using a pulse oximeter instead of invasive ar-
terial blood gas samples has been suggested.113-118 Inaccuracy in pulse oxi- 
metry readings at saturations ≤ 85% has been reported, even suggesting that 
at saturations ≤ 85%, pulse oximetry alone should not be relied on in making 
clinical decisions.119 Moreover, some authors have excluded SpO2 values 
>97% in the pulse oximeter based estimates, since in this range large changes 
in PaO2 result in minimal change in SpO2113, 114, 120 due to the oxygen disso-
ciation curve. On the other hand, similar discrimination between pulse ox-
imetry-based values and PaO2/FiO2 based values have been shown for PIM3 
when all (SpO2 0-100%) pulse oximetry values were used in a transport co-
hort.116
We found that PIM2 and probability of death was not altered when the 
PaO2/FiO2 was excluded from the logit equation, not for the entire study 
population nor for the non-respiratory group. Nonetheless, predictabili-
ty was decreased for the respiratory group when probability of death was > 
10%, if PaO2/FiO2 was omitted from the equation. There is no clear solution 
to the problem with the frequently missing PaO2 values. However the results 
from this thesis suggest that it is not necessary to perform a blood gas sample 
in clinical practice since the PIM2 score mortality prediction is not limited, 
unless the child belongs to the respiratory group and a rather high severity of 
illness is suspected or if otherwise clinically indicated (circulatory monitor-
ing, acid base-status, gas exchange etc.). 
6.1.3 Study IV and V
During air transport the effects of altitude on patient oxygenation is of spe-
cial importance. With increasing altitude, the barometric pressure will de-
crease and as a result also the partial pressure of oxygen. On air ambulance 
flights exceeding 2 hours in a pressurized cabin the cabin altitude corre-
sponds to 7000 feet. Normal flying altitude (about 1-hour flight time), usually 
corresponds to 5000 feet inside the cabin. The current routine during trans-
port is monitoring by pulse oximetry. This provides a continuous assessment 
of arterial oxygen saturation, but no estimate of tissue oxygen demand or an 
oxygen delivery imbalance, which could be of great interest especially in cer-
tain patient categories such as patients with cyanotic heart malformations or 
necrotizing enterocolitis.
Approximately 60 % of all transports performed by PETS are done by 
air-ambulance, among them are children transferred for open heart surgery. 
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As outlined in the Background section, the focus on NIRS utilization with-
in the scope of this thesis has been on its use in a transport environment. 
Among the limitations with the NIRS technology mentioned earlier by oth-
ers are technical issues such as different optical probes, sensors and algo-
rithms in commercial devices which makes comparisons and reference val-
ues difficult.74, 121, 122 Authors have also pointed out that noise reduction 
remains the most important factor in improving accuracy and precision of 
signal interpretation in vivo.68 
When setting out to conduct Study V, we realized that NIRS real time 
readings were sometimes unreliable during transport and that individual 
values varied greatly, resulting in uncertainty. We therefore had to take a step 
back and find a way to improve the method before we could carry on with 
our study. We went back to analyze the electronically stored data and found 
that there was a great deal of artefacts (i.e. zero-values and “floor-effect” va-
lues) and noise in the signal. When making a literature search we under-
stood that a particular method had been recognized by many for its ability 
to retrieve original signal structure while removing noise also in biomedical 
signal processing.103, 104, 123-125 This algorithm has had a huge impact on the 
start of computer controlled analytical instruments, which was high-light-
ened when the scientific journal “Analytical Chemistry” in 2000 published 
an edition on the 10 most-cited papers from 1945 to 1999 and the original 
article written by Savitzky and Golay was one of them.126 
We therefore introduced the Savitzky-Golay algorithm of smoothing and 
differentiation of data by simplified least square procedures (least-squares 
fitting) to perform noise reduction on the signal and thereby enable better 
signal evaluation, after the collected data had been cleared for artefacts. The 
second order of smoothing polynomial was used and the optimal number of 
neighboring points (“window-size”) for the smoothing procedure was de-
termined to avoid distortions of the signal. This resulted in a methodologi-
cal study (Study IV) where we showed that by using this filtering method, we 
could perform noise reduction in the signal with very low signal distortion, 
which made it possible to relate signal changes to physiological events dur-
ing transport. As an interesting finding in Study IV we observed that poor 
signal acquisition in the splanchnic sensor was most pronounced in children 
who had had previous abdominal surgery. The underlying reason is uncer-
tain, possibly scarring of the subcutaneous tissue with inferior penetrating 
conditions for the near-infrared light can be responsible for this observation.
Study V is the first study to investigate regional tissue oxygen saturation 
with multisite registrations from both cerebral and splanchnic areas during 
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inter-hospital transport of critically ill children. In Study V we used the 
smoothing method to visualize different patterns of reacting to altitude in 
different patients. Both cerebral and splanchnic oxygen saturation decreased 
with statistical significance at altitude ≥ 5000 feet compared to baseline in a 
majority of patients and in most patients cerebral oxygen saturation was pre-
served more than splanchnic oxygen saturation. The clinical implication of 
this finding is unclear, however. Previous research has defined low rSO2‐C 
as a continuous decrease of > 20% from baseline.65, 72, 76, 82, 127 We found 
this in only one patient, who also showed a simultaneous decrease in SpO2. 
If the same decrease of > 20% from baseline was applied to rSO2‐A, using 
the information that rSO2‐A values in healthy newborns have been found 
to resemble rSO2‐C values by 48 h postnatal age,73 we could observe this re-
duction in four patients, one without a simultaneous decrease in SpO2. A 
more profound decrease in rSO2‐C and/or rSO2‐A than in SpO2 was found 
in 5 patients, most obvious in rSO2‐A. On the other hand, a substantial de-
crease in SpO2, without a corresponding decrease in rSO2‐C and rSO2‐A was 
found in 6 patients. We speculate that this might imply that cerebral tissue 
was protected by auto‐regulation in this increasingly hypoxic environment 
and that splanchnic tissue was a leading indicator. Altogether we found that 
measurements of rSO2‐A involved more difficulties than rSO2‐C, but also 
gave more information in addition to measurements from pulse oximetry 
than did rSO2‐C. Ideally oxygen extraction would have been a more reli-
able measurement which could have provided additional information, but 
we were not able to extract continuous data from the pulse oximetry device, 
which limited this possibility. We believe that by combining regional oxygen 
saturation and the smoothing technique on line, NIRS has the possibility to 
become a useful technique to guide therapy to avert poor tissue-specific and 
global outcomes.
6.2 Methodological considerations
There are both strengths and limitations of the studies included in this thesis 
that might have interfered with results and interpretations.
A main limitation of both Study I and II is their retrospective nature as 
well as their lack of matched control groups. 
Moreover, since the PIM2 score was collected from the first hour of PICU 
admission (rather than first contact with the transport team) it is possible 
that the PIM2 was inaccurate (physiology having been altered by interven-
tions during transport) in both studies. The studies also evaluated outcomes 
for a single transport team and PICU, which is a limitation. A strength of 
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A main limitation of both Study I and II is their retrospective nature as 
well as their lack of matched control groups. 
Moreover, since the PIM2 score was collected from the first hour of PICU 
admission (rather than first contact with the transport team) it is possible 
that the PIM2 was inaccurate (physiology having been altered by interven-
tions during transport) in both studies. The studies also evaluated outcomes 
for a single transport team and PICU, which is a limitation. A strength of 
51
52
the studies is the linking of PICU data to a national registry to evaluate long-
term survival, furthermore in both Study I and II consecutive patients were 
included, categorized by diagnoses set by the treating physician in the PICU 
and not by the researchers involved. In Study II patients were sorted by age 
or PDR at admission, the latter also scored by a PICU physician and data re-
trieved from PDMS. A possible selection bias could be the nature of the PICU 
being a tertiary center, where patients were transported for high-risk condi-
tions such as intracranial bleeding accepted for neurosurgery, near-ECMO 
conditions or for continuous renal replacement therapy. In this perspective 
a case control study might have been a preferable method. No premature ba-
bies were included in any of the studies, nor patients transported to the neo-
natal intensive unit (NICU) since the PIM scoring system is not used in the 
NICU. Regarding Study II it might have been of additional value to divide 
the study group into two (2008-2013 and 2014-2016) to account for the ef-
fect of time on outcomes. It is likely that the reasons for death in the longer 
term are due to the chronic nature of the illnesses that the children may have 
had. A retrospective cohort analysis of 52,791 pediatric admissions to PICUs 
in the US stated that 53% of all admissions had a complex chronic condition. 
These children had a longer LOS and higher risk for PICU mortality than 
children without comorbidity.128 Therefore, the absence of functional status 
prior to admission as well as data on chronic comorbidities is a weakness. In 
addition, we lack data on morbidity after discharge.
In the same manner, the design in Study III was retrospective with con-
secutive admissions to a single PICU. The cohort size in Study III was not 
based on statistical power calculations, a decision based on the aim of the 
study to investigate if the absence of a blood gas sample significantly affects 
the PIM2 value, i.e. the aim was not to perform analyses versus mortality 
where a considerable number of patients would have been needed. The coeffi-
cient for PaO2/FiO2 in the PIM2 equation contributes with only 0.2620 to be 
compared with an absent pupil reaction which contributes with a coefficient 
of 2.704 indicating the low weight of PaO2/FiO2 in the PIM2 calculation. The 
choice of a cohort with a high number of admissions (55%) with a recorded 
arterial blood gas sample was a strength. Previously reported percentages 
vary from 1.4 to 51.7% recorded PaO2 values at admission.88, 113, 115, 129 In the 
original article on the updated version PIM3, 44.2% of patients included had 
a recorded PaO2 value.88
In Study IV and V a well-established and robust model for filtering tech-
nique was used, which should be considered to be advantageous. In both 
studies, data were evaluated and processed after the transport. Conclusions 
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on applicability of this method on line during the actual transport may there-
fore not be drawn in the scope of this thesis and should ideally be examined 
separately. Premature children were not included in any of the studies. Most 
children were neonatal patients with a median age of 9.5 and 12 days in the 
two studies, respectively. Consequently, a significant proportion of hemoglo-
bin (Hb) in the blood would be fetal if the child had not been transfused with 
adult blood. In a study aimed to determine whether it is necessary to modi-
fy the coefficients used in NIRS calculations when fetal Hb is present it was 
shown that adult Hb coefficients can be applied to newborns, irrespective 
of the level of fetal Hb, without introducing a significant error.130 In Study 
V a Hb measurement was not documented in 25% of patients at the time of 
transport, this could influence both rSO2‐C and rSO2‐A levels, but since each 
patient served as its own control, we think this effect is insignificant for the 
results. NIRS data were collected as continuous data which resulted in large 
numbers of data, while data from pulse oximetry on the other hand were col-
lected as single values. 
6.3 Clinical implications
Critically ill children can be transported, regardless of the distance, without 
increasing their risk of death provided that the team members are experi-
enced in pediatric intensive care, and the equipment appropriate. 
Transported children show a high mortality rate also after PICU dis-
charge, especially during the first six months, and especially in children 
transported multiple times. Therefore, survival after transport should if pos-
sible be presented as survival after 90-days. In addition, the PIM score may 
be used in predicting 30-day and 90-day mortality, not only PICU mortality.
It is not necessary to have a blood gas sample just to fill in the PIM score. 
It should be taken when clinically indicated.
NIRS monitoring has potential benefit when cleared for artefacts and 
smoothened by a noise-reduction algorithm. It may serve as a complement to 
existing monitoring during inter-hospital air ambulance transport, especial-
ly in children with certain diagnoses such as cyanotic heart malformations. 
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7  CONCLUSIONS
Based on this thesis the conclusions are that:
• When transported by a specialized pediatric transport team critically ill 
children can be transferred, regardless of the distance, without increasing 
their risk of death. Despite a higher severity of illness and an increased 
use of PICU resources among transported children, the Standardized 
Mortality Ratio was similar to other acute admissions to PICU.
• A difference in survival among age-groups could not be demonstrated in 
transported patients, PICU resources such as iNO and ECMO were more 
common in the neonatal group. Overall, there was a significant mortality 
after PICU discharge which implies that survival to PICU discharge may 
not be the best measure of outcome for this group of patients. 
• A PaO2/FiO2 value for the PIM score is needed only when the patient be-
longs to the respiratory group and a rather high severity of illness is ex-
pected. 
• Reliable NIRS data can be obtained during transport when cleared for arte- 
facts and smoothed by a noise-reduction algorithm.
• There was a decrease in both cerebral and splanchnic oxygen saturation 
as an effect of altitude, however cerebral oxygen saturation was better pre-
served than splanchnic. The clinical impact has still to be investigated, 
but NIRS has the potential to give insight into physiological processes 
during air-ambulance transports. 
54
7  CONCLUSIONS
Based on this thesis the conclusions are that:
• When transported by a specialized pediatric transport team critically ill 
children can be transferred, regardless of the distance, without increasing 
their risk of death. Despite a higher severity of illness and an increased 
use of PICU resources among transported children, the Standardized 
Mortality Ratio was similar to other acute admissions to PICU.
• A difference in survival among age-groups could not be demonstrated in 
transported patients, PICU resources such as iNO and ECMO were more 
common in the neonatal group. Overall, there was a significant mortality 
after PICU discharge which implies that survival to PICU discharge may 
not be the best measure of outcome for this group of patients. 
• A PaO2/FiO2 value for the PIM score is needed only when the patient be-
longs to the respiratory group and a rather high severity of illness is ex-
pected. 
• Reliable NIRS data can be obtained during transport when cleared for arte- 
facts and smoothed by a noise-reduction algorithm.
• There was a decrease in both cerebral and splanchnic oxygen saturation 
as an effect of altitude, however cerebral oxygen saturation was better pre-
served than splanchnic. The clinical impact has still to be investigated, 
but NIRS has the potential to give insight into physiological processes 
during air-ambulance transports. 
54
55
8  FUTURE  
 PERSPECTIVES 
• In this thesis we have found that transported children showed a continuous 
mortality risk after PICU discharge. In a future study it would be interes-
ting to investigate the morbidity and functional status among transport-
ed patients, as well as all PICU patients in a longitudinal fashion after 
PICU discharge and correlate these findings to functional status inclu-
ding complex chronic conditions prior to transport/admission. 
• In the future a national (or Scandinavian) multicenter study on outcomes 
in transported children would be both enlightening and educational, 
preferably in combination with the construction of a transport database 
for the pediatric population, for reporting of adverse events and improve-
ment of practices.
• With respect to response time for a specialized transport team, especially 
in a country like Sweden with significant geographical distances, a valu-
able study would be to investigate whether telemedicine could be a help-
ful tool for referring hospitals in the assessment before retrieval and for 
advice while waiting for the transport team to arrive.
• As stated by the SBU (see the Background chapter of the thesis) there are 
four steps in the evaluation of diagnostic tests with the last step being the 
question if outcome is better for patients undergoing the test compared 
with similar patients who did not undergo the test. Further studies are 
still needed to answer this question regarding NIRS utilization during 
inter-hospital transports. As a next step we plan to investigate the effect 
of altitude on oxygen extraction in transported children, to achieve this a 
pulse oximeter with capacity to download electronically stored continu-
ous data would be necessary. 
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This thesis project has taken more than five years to complete and it has been 
a continuous learning process from many sources. 
The academic courses have been appropriate for this project and laid the 
groundwork to an increased knowledge on scientific thinking and general 
scientific methodology. By examining research articles and by theoretical 
studies during a course in methods for systematic literature review I have 
improved my skills in critical evaluation of research articles.
This knowledge has then been used in a very practical and obvious way 
in the process of working on a project from the formulation of a hypothesis 
and the methodological planning to analysis, interpretation and implemen-
tation of the results. Looking back, I can see how much I’ve learned from the 
process of working on Study I, which was strenuous and took a lot of time. In 
the same manner, the manuscript was difficult to write and took a long time 
to finish, moreover the initial submission was refused by two scientific jour-
nals before it was accepted by a third with major revisions. Indeed, this pro-
cess was highly valuable, I had to be open to criticism and it made me reflect 
on my research in different contexts which I have benefited greatly from in 
terms of study limitations, interpretation of study results and how to improve 
its presentation in future scientific manuscripts.
The thesis has had a few different aspects i.e. epidemiologic studies as 
well as methodological studies with the application of a method, undoubted-
ly this has given me experience both in creating and conducting studies with 
different approaches and designs and the scientific breadth has been chal-
lenging but educative. By the work on this thesis I have gained experience in 
formulating a research hypothesis, creating a data base fit for use, in plan-
ning studies for a clinical setting and being prepared for unforeseen events 
which may occur and affect the implementation. The feedback from supervi-
sors, co-authors and reviewers while revising manuscripts has been invalu-
able. I cannot overemphasize how much this has helped me in improving my 
ability to analyze and draw conclusions from my work.
Another great source of learning has been academic meetings where I’ve 
been given the opportunity to present my research either orally or as poster 
presentations. While preparing to present my research in such an environ-
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ment I have had to reflect on weaknesses, how to summarize conclusions 
from my work, how to meet criticism and what results mean and how they 
contribute to the body of knowledge in this field. 
Altogether, as a clinician since many years, it has been an absolute privi-
lege to work with medicine from the research perspective. I have been even 
more fortunate since I have been able to conduct my research and this thesis 
in an area which I have been extremely interested in from a clinical perspec-
tive, and to combine it with research has been awesome. I have received in-
valuable help from my supervisors who have believed in me and this project 
and who have helped me to grow as a scientist. I am sure this academic train-
ing will be beneficial for my possibilities to contribute to future patient bene-
fit, research and practice in health work.
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